rs9350271
This is a intron variant variant in the CDKAL1 gene.
▶GWAS Catalog Trait Associations (4)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (4)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
type 2 diabetes mellitus
Spracklen CN et al. “Identification of type 2 diabetes loci in 433,540 East Asian individuals.” Nature 582(7811):240-245 (2020)
Allele A
OR 1.21
p 5.0e-183
N 433,540
Large GWAS
East Asian
Ishigaki K et al. “Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.” Nature Genetics 52(7):669-679 (2020)
Allele A
OR 1.19
p 2.0e-93
N 210,865
Large GWAS
East Asian
Walters RG et al. “Genotyping and population characteristics of the China Kadoorie Biobank.” Cell Genomics 3(8):100361 (2023)
Allele A
OR 1.16
p 7.0e-10
N 77,178
Large GWAS
East Asian
promotilin measurement
Pietzner M et al. “Mapping the proteo-genomic convergence of human diseases.” Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele A
OR 0.11
p 3.0e-15
N 10,708
Large GWAS
European
erythrocyte volume
Vuckovic D et al. “The Polygenic and Monogenic Basis of Blood Traits and Diseases.” Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.02
p 4.0e-12
N 408,112
Large GWAS
European
diabetes mellitus
Walters RG et al. “Genotyping and population characteristics of the China Kadoorie Biobank.” Cell Genomics 3(8):100361 (2023)
Allele A
OR 1.16
p 4.0e-8
N 77,194
Large GWAS
East Asian
About CDKAL1
The protein encoded by this gene is a member of the methylthiotransferase family. The function of this gene is not known. Genome-wide association studies have linked single nucleotide polymorphisms in an intron of this gene with susceptibilty to type 2 diabetes. [provided by RefSeq, May 2010]
View all CDKAL1 variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…